Homepage / Investment / These high-flying life sciences stocks make Netflix and Amazon look dull
Les Gambling establishments en Ligne en France 2024 200% Reward + 300 Free Rotates LevelUp Internet casino Melbourne En İyi ve Güvenilir Casino Siteleri Canlı Casino Siteleri 2023 Listesi En İyi ve Güvenilir Casino Siteleri Canlı Casino Siteleri 2023 Listesi Le meilleur casino en ligne franзais Extra Casino avec le dйpфt minimal le in addition bas Yeni Casino Siteleri ᐈ Çevrimiçi Kumarhaneler Mart 2024 Les gambling establishments en ligne proposent une grande variйtй de jeux de internet casino gratuits. Türkiye’deki Resmi Web Sitesi Google Play, Türkiye’de kumar oyunlarına izin verecek Her Gün Tatil Olsa ORDU’DA PAZARTESİ GÜNÜ FINDIK FİYATI NASIL? كازينو اون لاين الكازينوهات الممتازة على الإنترنت ألعاب الكازينو المباشرة مينا كازينو العر Google Play, Türkiye’de kumar oyunlarına izin verecek Domain Sorgulama & Domain Fýrsatlarý Canlı Casino Siteleri: 2024 Güvenilir Siteler Seçilmiştir Golden Easter Slot İncelemesi 2024, Demoyu Ücretsiz Oynayın Golden Easter Slot İncelemesi 2024, Demoyu Ücretsiz Oynayın 1xbet Türkiye Giriş Empieza Kayıt 202 Kumar Ve Kumarhaneler Hakkında Pek İlginç 21 Bilgi Kumarhane Doğru Yazımı Nedir? Tdk Ile Kumarhane Kelimesinin Doğru Yazılışı! Mobilbahiste En İyi Kumar Bonusları Ve Kazançlar Mobilbahis Giriş Sayfası On Line Casino Siteleri En Iyi Casino Siteleri 2024 Mostbet: Türkiye’de Internet Casino Mostbet Online Slotlar Ve Canlı-casin Pin Up Casino Oyna Türkiye, Pinup’un Sah Web Sites Ifade Haberleri Son Dakika Ifade Hakkında Güncel Haber Ve Bilgiler “önceliğimiz Transferin Önünü Açmak, Görüştüğümüz Yerler Var” On Line Casino Nuh’un Gemisi Deluxe Resort & Spa, Kıbrıs Bonus Veren Siteler 3 000 Den Fazla Online Oyunu Ücretsiz Oyna En Tehlikeli Kumar Oyunu Ekşi Sözlük Deneme Bonusu Veren Siteler Deneme Bonusu 2024 Explore the Magic of WildCardCity Güvenilir Bahis Siteleri En İyi Kumar Siteleri Balıkesir Triatlonuna Avrupadan Ödül Tricks of the Aviator gambling establishment game by Spribe Çevrim Içi Kumar Siteleri “bonus” Yalanıyla Kandırıyor En Güvenilir Canlı On Line Casino Siteleri Xbetting-tips Com Uncovering the Abundant Tapestry of Ozwin Gambling establishment Evaluating Board Portal Providers Uncovering the Wealthy Tapestry of Ozwin On line casino Electronic Data Area Providers Evaluation Cobra Internet casino: Raising the Australian On the internet Video gaming Practical experience 4 Things to Search for in Safeguarded Cloud Safe-keeping Fastpay On line casino Australia – Simple and No-Taxation Wagering Web page officielle franзaise de Joka Gambling establishment The Software Development Universe Game Woo Internet casino – Enjoy Slot machine games around australia Ostdeutsche Biersorten What Are Virtual Data Rooms? Vitamin D Receptor Polymorphisms Revue du Casino BlackLabel Faktory, kterй ovlivnujн hodnocenн ceskэch online kasin How to Make the Most of Your Web Development Organization and Advertising Efforts L’essor des casinos en ligne en France Boost Meeting Efficiency With Boardroom Technology Developments WildJoker Casino WildCardCity On line casino – Guaranteed Australian Gambling Portal WildCardCity Casino – The Ideal On the internet Gambling establishment within australia Modern Technologies Produce Sharing Documents Online Faster and More Protect Free Virtual Info Room pertaining to Speedy Due Diligence A Review of Data Area Software For people who do buiness Five Board Bedroom Features Which will help You Acquire a More Productive Boardroom Electronic Systems To your Business Understanding Legal Terms and Laws in Today’s World The Laws and Contracts of Hollywood: A Sunset Blvd. Tale Legal Discussion Between Johnny Cash and Antonin Scalia Legal Insights: What Teens Should Know Legal Issues and Exceptions: What You Need to Know Legal Insights and Expert Analysis Celebrity Dialogue: Legal Matters in the 21st Century Famous Personalities Discuss Legal Issues The Boys in the Boat: Legal Advisors and The Quest for Legal Knowledge Understanding Legal Matters: Q&A on Criminal Law, Joint Ventures, and More Enticing Title The Departed: Understanding Basic Work Requirements and Legal Rights Youth Slang Blog Article Legal Insights: A Journey into the World of Law The Ins and Outs of Legal Matters: Everything You Need to Know Legal Insights and Trends: A Rap Guide Mysterious Legal Matters Unveiled Insights and Information: Understanding Various Laws and Regulations Famous People of the 21st Century The Circle of Legal Life The Intersection of Fashion Law, Legal Translation, and THC Oil: A Modern Legal Guide Legal Q&A: Understanding Joinder Federal Rules and More Understanding Legal Terms and Conditions: A Comprehensive Guide Understanding Legal Documentation in a Fun Way! Understanding Legal Aspects: From Islamic Law of Inheritance to Farm Law Protests Understanding Legal Rights: A Guide to Legal Regulations and Requirements Understanding Legal Guidelines and Agreements Famous 21st Century People in Conversation Mysterious Legal Matters Unveiled Legal Matters and Real Estate: A Conversation Between Cameron Boyce and Donald Trump Understanding Legal Expertise and Why It Matters Legal FAQs and Expert Services Understanding Legal Ramifications: Common Law Ontario Health Benefits and More The Ins and Outs of Legal Requirements: From FBI Academy Physical Requirements to Silver Lake Fishing Rules The Legal Underworld: Understanding the Significance of Laws and Rights Legal Conversations: A Dialogue Between Jon Jones and Chadwick Boseman Legal Beats: Bobcats, Real Estate, Babysitting, and More

Investment

These high-flying life sciences stocks make Netflix and Amazon look dull

The giants of the internet economy are typically cast as the leading fetish objects for growth investors. But compared to the TAMP stocks, FANG looks a bit dull.

What’s TAMP, you ask? That would be Thermo Fisher Scientific, Agilent, Mettler-Toledo and PerkinElmer, just a few of the seldom-discussed names that have powered the obscure S&P 500’s life sciences tools & services subsector to a 41 percent year-to-date gain.

By comparison, FANG – Facebook, Amazon, Netflix and Google parent Alphabet – are up less than 36 percent this year on an equal-weighted basis.

The life sciences tools group — which also includes Illumina, Waters and Quintiles IMS — totals more than $170 billion in market value (about equal to the size of Intel). The companies fall within the health-care sector, but they neither discover cures nor deliver care. They provide lab equipment, testing supplies, analytical devices and services to the pharmaceutical and biotech industries, as well as some chemical and industrial customers.

Part of their appeal to investors in an aging and slow-growing world: They profit from the volume of new-drug investigations and lab tests, favorable demographics and the total amount of health care delivered globally but they don’t have direct regulatory risk from drug-price controls or an Obamacare repeal.

It helps, too, that the companies generally are steady long-term performers that have done many bolt-on acquisitions in their chosen product areas and tend to convert mid-single-digit sales growth into low-double-digit per-share earnings expansion.

A strong and sustained rally in a cluster of stocks will always have a tidy fundamental story behind it, and here’s the case for the lab-products names, according to analyst Paul Knight at Janney Montgomery Scott:

“Even with a sector showing strong performance in 2017, the fundamental backdrop for life science tools is becoming a ‘Goldilocks’ situation. Asia is the largest tools market and growth is in double digits, industrial demand is increasing with robust PMI indicators at seven-year highs, and currency tailwinds are developing.”

S&P 500/Life Sciences Tools & Services versus S&P 500 (YTD)

Source: FactSet

More drug investigations and approved treatments, of increasing complexity, are expected. The booming field of immunotherapy development is a growth engine in itself, requiring complex material-handling and storage processes.

It all nets out to a dream growth-investor arrangement: Long-lived demographic forces, resistance to the economic cycle, stable business-to-business supply relationships, global distribution, and a “razors and blades” recurring-sales model.

The fact that these attributes have propelled such gaudy share-price gains, though, makes it worth asking whether professional investors are crowding into these names to hide from policy or macro threats that might, at some point, fade away.

In the current phase of the bull market, “reliable growth companies” that play a middleman role in de facto oligopolies have hogged a lot of the oxygen, at the expense of more cyclical plays, and especially consumer-facing companies whose moats are seen to be drying up.

Retail, media, branded-clothing and packaged-food stocks are suffering, as investors implicitly shun businesses that require consumers to make an active, conscious decision to spend on a product. Internet platforms, payment processors, aerospace, semiconductors and, yes, health-care tools companies have been enriched at their expense.

The result, for the life-sciences supply names, is valuations at the very high end of the stocks’ own historical range. The TAMP stocks and their peers are now fetching between 20 and 40 times projected earnings for the coming year, compared to around 18 for the broader market. And, remember, these are companies generally growing not much faster than nominal world GDP, with admittedly attractive profit margins.

Technical analysts tend to love the group, identifying what look like sturdy long-term uptrends, even if some appear a bit stretched in the short term (note that the sector shed 1 percent on Tuesday in a largely flat market).

The risk to investors at these prices for the likes of Mettler-Toledo, PerkinElmer or Illumina is not that the companies stumble or laboratory volumes roll over. The stocks, instead, could be exposed to a change in investor preferences and outlook on the world.

If the bull market sputters, of course, it would not be kind to once-sleepy growth stocks at premium multiples. And if, instead, confidence grows in the economic-growth outlook and central banks do allow interest rates to rise, fewer investors might feel the need to hide in this corner of the health-care sector.

The question is not whether these are good businesses. They are. The riddle is always what assumptions motivated the last buyer of the stock of a fine business, and what price might be too high to pay for one.

Source: Investment Cnbc
These high-flying life sciences stocks make Netflix and Amazon look dull

Comments are closed.